Literature DB >> 32992264

Current perspectives on the immunopathogenesis of sarcoidosis.

Silvia Lee1, David Birnie2, Girish Dwivedi3.   

Abstract

Sarcoidosis is an inflammatory systemic disease that commonly affects the lungs or lymph nodes but can manifest in other organs. Herein, we review the latest evidence establishing how innate and adaptive immune responses contribute to the pathogenesis and clinical course of sarcoidosis. We discuss the possible role of microbial organisms as etiologic agents in sarcoidosis and the evidence supporting sarcoidosis as an autoimmune disease. We also discuss how animal and in vitro human models have advanced our understanding of the immunopathogenesis of sarcoidosis. Finally, we discuss therapeutics for sarcoidosis and the effects on the immune system.
Copyright © 2020 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Adaptive immune responses; Innate immune responses; Sarcoidosis

Mesh:

Substances:

Year:  2020        PMID: 32992264     DOI: 10.1016/j.rmed.2020.106161

Source DB:  PubMed          Journal:  Respir Med        ISSN: 0954-6111            Impact factor:   3.415


  4 in total

Review 1.  Renal sarcoidosis.

Authors:  Marta Calatroni; Gabriella Moroni; Francesco Reggiani; Claudio Ponticelli
Journal:  J Nephrol       Date:  2022-06-27       Impact factor: 4.393

2.  BATF2 and PDK4 as diagnostic molecular markers of sarcoidosis and their relationship with immune infiltration.

Authors:  Jie He; Xiaoyan Li; Jing Zhou; Rong Hu
Journal:  Ann Transl Med       Date:  2022-01

Review 3.  The role of PET in the management of sarcoidosis.

Authors:  Robert J Vender; Hamad Aldahham; Rohit Gupta
Journal:  Curr Opin Pulm Med       Date:  2022-07-16       Impact factor: 2.868

Review 4.  Lung Microbiome in Idiopathic Pulmonary Fibrosis and Other Interstitial Lung Diseases.

Authors:  Francesco Amati; Anna Stainer; Marco Mantero; Andrea Gramegna; Edoardo Simonetta; Giulia Suigo; Antonio Voza; Anoop M Nambiar; Umberto Cariboni; Justin Oldham; Philip L Molyneaux; Paolo Spagnolo; Francesco Blasi; Stefano Aliberti
Journal:  Int J Mol Sci       Date:  2022-01-17       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.